Following a successful Korea launch, MEPSGEN brings advanced microfluidic technology to U.S. researchers NanoCalibur™ offers precise, scalable, and reproducible nanoparticle production for drug development MEPSGEN’s CEO to present new technology at the 4th LNP Formulation & Process Development Summit, on April 15, in Boston. BOSTON — MEPSGEN US Inc., a global innovator in scalable nanoparticle production technology, announced today the launch of NanoCalibur™, a […]

First multiplexed solution introduced with the next-generation Cyto-Mine Chroma platform for more efficient biotherapeutic development Utilizes advanced picodroplet microfluidics technology to integrate analysis of antibody productivity and cell viability of monoclonal antibody producing cells Cambridge, UK: Sphere Bio, a leading provider of innovative picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, today announced the launch […]

Bethlehem, PA — ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform poised to transform cell expansion for Advanced Therapy Medicinal Products (ATMPs). Designed to overcome the limitations of currently available systems, the ATB™ delivers unprecedented process control and scalability from […]

Bethlehem, PA – ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform poised to transform cell expansion for Advanced Therapy Medicinal Products (ATMPs). Designed to overcome the limitations of currently available systems, the ATB™ delivers unprecedented process control and scalability from bench […]

FARMINGDALE, N.Y. — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and to have its common stock quoted on the OTCQX Best Market (“OTCQX”). Enzo provided notice of the voluntary delisting to the NYSE on March 28, […]

FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Gregory J. Hayes to its board of directors, effective March 26, 2025. BD appoints Gregory J. Hayes to its board of directors. Hayes, 64, is currently the executive chairman of the board of […]

  I&L Biosystems is excited to introduce the VERLO™ Image-Guided Cell Sorter that combines flow cytometry, gentle microfluidic sorting, and imaging to sort cells by morphology and localisation. With two lasers and 12 parameters, it enables bulk and single-cell sorting. The VERLO™ Image-Guided Cell Sorter by NanoCellect utilises patented microfluidic-based sorting, combining laser excitation with sensitive PMT detectors […]

New alliance for advanced biological imaging aimed at enhancing some of the world’s most innovative structural cell biology capabilities to help scientists answer pressing research questions WALTHAM, Mass. —  Thermo Fisher Scientific Inc., the world leader in serving science, has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ […]

COLOGNE, GERMANY – Singleron Biotechnologies today announced the launch of MobiuSCOPE, a single cell RNA sequencing kit that provides full-length transcript analysis using standard short-read sequencing. This solution captures alternative splicing events, gene fusions, and single nucleotide polymorphisms (SNPs) by providing complete transcript coverage and minimizing the 3′ or 5′ bias commonly found in conventional approaches. […]

PISCATAWAY, NJ — GenScript, a global leader in life science research and application services, is excited to announce that it has been awarded the Bronze Medal by the internationally renowned provider of business sustainability ratings EcoVadis. This prestigious recognition places GenScript in the top 35% of over 130,000 companies assessed for their commitment to sustainable practices. […]